What is the management of adrenal myelolipoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of adrenal myelolipomas should prioritize a conservative approach, with small, asymptomatic myelolipomas (less than 4 cm) requiring no further follow-up, as per the latest guidelines 1.

Key Considerations

  • The latest study from 2023 1 provides the most up-to-date guidance on the management of adrenal myelolipomas.
  • Myelolipomas are typically benign and composed of mature adipose tissue and hematopoietic elements, with an extremely low malignant potential.
  • The size and symptoms of the myelolipoma should guide management decisions.

Management Approach

  • Small, asymptomatic myelolipomas (less than 4 cm) do not require further follow-up imaging or functional testing, as stated in the 2023 guidelines 1.
  • For myelolipomas between 4-7 cm, management decisions should be individualized based on patient factors and symptoms.
  • Surgical intervention is recommended for myelolipomas that are symptomatic, larger than 7 cm, or showing rapid growth on serial imaging.
  • The preferred surgical approach is laparoscopic adrenalectomy, which offers shorter hospital stays and faster recovery compared to open surgery.

Additional Recommendations

  • Patients should be evaluated for hormonal activity before any intervention, though myelolipomas are typically non-functional.
  • Pain management may be necessary for symptomatic cases using standard analgesics.
  • The conservative approach for smaller lesions is justified by the benign nature of myelolipomas and their extremely low malignant potential.
  • Patients should be reassured about the benign nature of these lesions while being monitored appropriately, with a focus on minimizing morbidity, mortality, and improving quality of life.

From the Research

Management of Adrenal Myelolipoma

The management of adrenal myelolipoma can be divided into several approaches, including:

  • Watchful waiting for small asymptomatic tumors
  • Surgical removal for symptomatic or large tumors
  • Laparoscopic adrenalectomy as a preferred surgical method

Indications for Surgery

Surgery is indicated for:

  • Symptomatic tumors
  • Tumors larger than 4 cm
  • Tumors with increased size on follow-up
  • Atypical appearance on imaging
  • Tumors causing acute clinical symptoms, such as intraperitoneal hemorrhage 2

Surgical Techniques

Several surgical techniques can be used, including:

  • Open adrenalectomy
  • Laparoscopic adrenalectomy
  • Hand-assisted laparoscopic partial adrenalectomy
  • Adrenal sparing surgery, which can be considered for appropriate removal of adrenal myelolipoma, even in giant adrenal myelolipoma 3

Postoperative Outcomes

Postoperative outcomes are generally favorable, with:

  • Low morbidity and mortality rates
  • Short hospital stay
  • Quick recovery
  • Alleviation of symptoms and emotional burden due to tumor presence 4, 2

Diagnostic Tools

Diagnostic tools, such as:

  • Ultrasound (US)
  • Computed tomography (CT)
  • Magnetic resonance imaging (MRI)
  • Fine needle aspiration (FNA) cytology under CT or US control, can be effective in diagnosing adrenal myelolipomas and avoiding unnecessary surgery 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Laparoscopic adrenalectomy for adrenal myelolipoma.

Archivos espanoles de urologia, 2007

Research

Incidentally discovered adrenal myelolipoma. Report on 3 operated patients and update of the literature.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.